HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overexpression of phospholipid-hydroperoxide glutathione peroxidase in human dermal fibroblasts abrogates UVA irradiation-induced expression of interstitial collagenase/matrix metalloproteinase-1 by suppression of phosphatidylcholine hydroperoxide-mediated NFkappaB activation and interleukin-6 release.

Abstract
Phospholipid-hydroperoxide glutathione peroxidase (PHGPx) exhibits high specific activity in reducing phosphatidylcholine hydroperoxides (PCOOHs) and thus may play a central role in protecting the skin against UV irradiation-triggered detrimental long term effects like cancer formation and premature skin aging. Here we addressed the role of PHGPx in the protection against UV irradiation-induced expression of matrix metalloproteinase-1 (MMP-1). For this purpose, we created human dermal fibroblast cell lines overexpressing human PHGPx. Overexpression led to a significant increase in PHGPx activity. In contrast to a maximal 4.5-fold induction of specific MMP-1 mRNA levels in vector-transfected cells at 24 h after UVA irradiation, no MMP-1 induction occurred at any studied time point after UVA treatment of PHGPx-overexpressing fibroblasts. As interleukin-6 (IL-6) was earlier shown to mediate the UVA induction of MMP-1, we studied whether PHGPx overexpression might interfere with the NFkappaB-mediated IL-6 induction and downstream signaling. Using transient transfections of IL-6 promoter constructs containing NFkappaB binding sites, we observed a high induction of the reporter gene luciferase in vector-transfected control cells and a significantly lower induction in PHGPx-overexpressing fibroblasts following UVA irradiation. Consistently both UVA irradiation and treatment of fibroblasts with PCOOHs led to phosphorylation and nuclear translocation of the p65 subunit, whereas cells overexpressing PHGPx exhibited impaired NFkappaB activation, p65 phosphorylation, and nuclear translocation. In line with this, the PHGPx-overexpressing fibroblasts showed a reduced constitutive and UVA irradiation-induced IL-6 release. After incubating PHGPx-overexpressing cells with PCOOHs a reduced induction of IL-6 was observed. This together with the suppression of UVA irradiation-induced IL-6 release in the presence of Trolox, a chain breaker of PCOOH-initiated lipid peroxidation, indicates that UVA irradiation-induced PCOOHs and subsequent lipid peroxides initiate the NFkappaB-mediated induction of IL-6, which mediates the induction of MMP-1. Our finding is particularly relevant in light of the already available small molecule mimetics of PHGPx.
AuthorsJutta Wenk, Jutta Schüller, Christina Hinrichs, Tatjana Syrovets, Ninel Azoitei, Maurizio Podda, Meinhard Wlaschek, Peter Brenneisen, Lars-A Schneider, Andrea Sabiwalsky, Thorsten Peters, Silke Sulyok, Joachim Dissemond, Matthias Schauen, Thomas Krieg, Thomas Wirth, Thomas Simmet, Karin Scharffetter-Kochanek
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 279 Issue 44 Pg. 45634-42 (Oct 29 2004) ISSN: 0021-9258 [Print] United States
PMID15308634 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • NF-kappa B
  • Phosphatidylcholines
  • RNA, Messenger
  • phosphatidylcholine hydroperoxide
  • Phospholipid Hydroperoxide Glutathione Peroxidase
  • Glutathione Peroxidase
  • Collagenases
  • Matrix Metalloproteinase 1
Topics
  • Active Transport, Cell Nucleus
  • Cell Line
  • Collagenases (genetics)
  • Fibroblasts (metabolism, radiation effects)
  • Gene Expression Regulation, Enzymologic (radiation effects)
  • Glutathione Peroxidase (physiology)
  • Humans
  • Interleukin-6 (biosynthesis)
  • Matrix Metalloproteinase 1 (genetics)
  • NF-kappa B (metabolism)
  • Phosphatidylcholines (physiology)
  • Phospholipid Hydroperoxide Glutathione Peroxidase
  • RNA, Messenger (analysis)
  • Skin (cytology, metabolism, radiation effects)
  • Ultraviolet Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: